PMID: 3772387Dec 1, 1986Paper

Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal

Journal of Neurochemistry
D D Flynn, D C Mash

Abstract

Putative nicotine receptors in the human cerebral cortex were characterized with L-[3H]nicotine, L-[3H]Nicotine binding was enhanced by the addition of Ca2+ and abolished in the presence of Na3EDTA. Association and dissociation of the ligand were rapid at 25 degrees C with t1/2 values of 2 and 3 min, respectively. Saturation binding analysis revealed an apparent single class of sites with a dissociation constant of 5.6 nM and a Hill coefficient of 1.05. There was no effect of postmortem interval on the density of binding sites assayed up to 24 h in rat frontoparietal cortex. Nicotine binding in human cortical samples was also unaltered by increasing sampling delay. In human cortical membranes, binding site density decreased with normal aging. Receptor affinity and concentration in samples of frontal cortex (Brodmann area 10) from patients with Alzheimer's disease were comparable to age-matched control values. Samples of infratemporal cortex (Brodmann area 38) from patients with Alzheimer's disease had a 50% reduction in the number of L-[3H]nicotine sites. Choline acetyltransferase activity was significantly decreased in both cortical areas. Enzyme activities in the temporal pole were reduced to 20% of control values. These data...Continue Reading

References

Mar 26, 1977·Lancet·P WhiteD M Bowen
Dec 29, 1978·Brain Research·T D ReisineS J Enna
Jul 4, 1985·The New England Journal of Medicine·P T FrancisG K Wilcock
Apr 16, 1986·Brain Research·P J WhitehouseK J Kellar
Jan 1, 1986·Journal of Neurochemistry·S ShimohamaM Kameyama
Jun 10, 1985·Brain Research·J O RinneU K Rinne
May 1, 1984·Journal of Neurochemistry·E HayashiS Yamada
Jul 1, 1984·Journal of Neuropathology and Experimental Neurology·C A Curcio, T Kemper
Jan 1, 1981·Pharmacology & Therapeutics·B J Morley
Jan 1, 1982·Annual Review of Biochemistry·B M Conti-Tronconi, M A Raftery
Mar 1, 1981·Journal of the Neurological Sciences·B E TomlinsonG Blessed
Nov 7, 1980·Science·C Romano, A Goldstein

❮ Previous
Next ❯

Citations

Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·A NordbergB Långström
Nov 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P T Francis, D M Bowen
Jul 1, 1988·Medicinal Research Reviews·W H MoosE R Gamzu
Jun 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·E Perry
Jul 1, 1994·Pharmacology & Toxicology·M OkamotoT Nakashima
Jun 20, 2003·Current Medical Research and Opinion·Michel BourinEric Dailly
Jan 22, 2011·International Journal of Alzheimer's Disease·Jin WuKenji Hashimoto
Jan 1, 1992·Psychopharmacology·P A NewhouseR Lenox
Jan 1, 1987·Molecular Neurobiology·J LindstromP Whiting
Jan 1, 1992·Psychopharmacology·E D Levin
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·E K PerryR H Perry
Jan 1, 1996·Psychopharmacology·E D Levin, D Torry
Sep 1, 1987·Human Toxicology·S Wonnacott
Nov 14, 2002·British Journal of Pharmacology·Ran-Sook WooKee-Won Kim
Sep 2, 2009·Nature Reviews. Drug Discovery·Antoine TalyJean-Pierre Changeux
Jun 28, 2016·CNS Drugs·Santiago Perez-Lloret, Olivier Rascol
Oct 30, 2019·EJNMMI Radiopharmacy and Chemistry·Solveig TiepoltOsama Sabri
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·L OlsonA Lilja
May 1, 1996·Molecular and Chemical Neuropathology·C Vidal
Aug 30, 2008·Journal of Neural Transmission·Richard T Reid, Marwan N Sabbagh
Jan 1, 1992·Reviews in the Neurosciences·C J Smith, E Giacobini
Aug 8, 2014·Frontiers in Aging Neuroscience·Sagar PatelValentina Echeverria Moran
Mar 18, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Roman RoyMarios Politis
Feb 18, 2016·NPJ Parkinson's Disease·Santiago Perez-Lloret, Francisco J Barrantes
Dec 1, 1990·Journal of Neuroscience Research·E Giacobini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.